Business
DarioHealth to Report Financial Results for the First Quarter 2020 Results on May 12
Earnings Discussion and Business Update Scheduled for 8:30 am Eastern Time NEW YORK, May 5, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)
About this update from Dariohealth Corp.
[{"type":"text","content":"Earnings Discussion and Business Update Scheduled for 8:30 am Eastern Time\n\n\nNEW YORK, May 5, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (\"DarioHealth\" or the \"Company\"), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial results on Tuesday, May 12, 2020, and host a conference call at 8:30am Eastern Time.\nThe call will be hosted by Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer.\nConference Call Details\nDate: Tuesday, May 12, 2020Time: 8:30 am EDTToll Free: 844-369-8770International: 862-298-0840Conference ID: DarioHealth First Quarter 2020 Earnings Call and WebcastWebcast: https://www.webcaster4.com/Webcast/Page/2224/34665\nParticipants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through May 26, 2020. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 34665. The webcast replay will be available through August 12, 2020.\nAbout DarioHealth Corp.\nDarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: http://mydario.com.\nDarioHealth Contact: Claudia Levi Content & Communications [email protected] 347-767-4220\nInvestor Relations Contact:Matthew PiccianoM...